Any link with A breakthrough-like effect of metformin reduces peripheral resistance to triiodothyronine in euthyroid, non-insulin-resistant, type 2 diabetic patients in: Endocrine Connections Volume 10 Issue 7 (2021)
Helvella?
Written by
MikeM46
To view profiles and participate in discussions please or .
Diabetics with comorbidities, newly diagnosed and untreated hypothyroid patients and hyperthyroid patients previously treated with either radioactive Iodine or surgery and now on replacement levothyroxine therapy, were excluded from the study.
The effect of metformin in significantly lowering TSH levels in hypothyroid patients on levothyroxine therapy without causing any changes in the circulating hormone levels has raised questions regarding the complexity of monitoring such patients.
Which, to me, indicates yet another reason to look at Free T4 and Free T3. Yet they appear to prefer the clinician to wait 6 to 12 months and then look at FT4 in conjunction with TSH.
Maybe we should ask what would happen to someone who actually does need more levothyroxine? Looks like they will have to wait up to a year. Let alone if they need T3...
Whereas I see it as yet another factor undermining TSH-only testing regimes.
Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind
Infante M, Leoni M, Caprio M, Fabbri A. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind. World J Diabetes. 2021;12(7):916-931. doi:10.4239/wjd.v12.i7.916
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.